Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LAV0 | ISIN: AU0000XINAJ0 | Ticker-Symbol: M2Z
Frankfurt
13.11.24
08:06 Uhr
0,027 Euro
-0,025
-48,08 %
1-Jahres-Chart
SEEING MACHINES LIMITED Chart 1 Jahr
5-Tage-Chart
SEEING MACHINES LIMITED 5-Tage-Chart
PR Newswire
608 Leser
Artikel bewerten:
(2)

Seeing Machines Limited: Seeing Machines unveils latest Guardian technology at CES 2024

Finanznachrichten News

- Guardian is the company's world-leading Aftermarket Driver Monitoring System for commercial vehicles and is currently connected to 54,000 vehicles globally

- The new version includes Drowsiness Detection with refined microsleep detection and eye-gaze tracking to protect drivers from risks associated with distracted driving

- New technology has been independently tested to meet the European Commissions' General Safety Regulation for Drowsiness Detection

CANBERRA, Australia, Jan. 9, 2024 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, is proud to launch Guardian Generation 3, the latest version of its Aftermarket Driver Monitoring System (DMS).

Guardian Generation 3 has been independently tested and confirmed to meet the European Commissions' General Safety Regulation for Drowsiness Detection, a requirement for all new cars, vans trucks and buses across Europe from July 2024. Guardian Generation 3 also features refined microsleep detection and eye-gaze tracking which enhances its ability to accurately detect distracted driving.

Seeing Machines has been protecting commercial transport and logistics companies with its aftermarket Guardian solution globally, with over 14 billion kilometres of recorded travel across 54,000 vehicles. The third generation Guardian hardware also delivers a range of features that leverage the Company's proven automotive-grade algorithms and precision optics to deliver premium performance in the most demanding real-world driving conditions.

As operators around the world continue to seek out reliable safety technology for their fleets, so too are commercial vehicle manufacturers. This enhanced Guardian technology offers compliance certainty for these OEMs who can now implement the technology via factory-fit or "after manufacture" and offer their customers the opportunity to buy fully compliant, road-ready vehicles.

Paul McGlone, CEO of Seeing Machines commented: "Regulation continues to drive demand for all of our DMS technology and I am very pleased to see that we have successfully launched the next generation of our Guardian solution for commercial transport and logistics companies as well as commercial vehicle manufacturers. A reliable solution that only activates when required is so important for driver adoption and continued road safety. Additionally, supporting commercial vehicle OEMs with an aftermarket (or factory fit) solution is critical to their ability to sell compliant vehicles. And, given the lower annual volume of production of these vehicles versus cars, I am delighted that Seeing Machines is able to service this new market segment profitably and continue to drive our purpose of getting people home safely."

Seeing Machines' Guardian Gen 3 will be on display for private demonstrations at CES 2024. For further information, please view our CES 2024 preview video here.

About Seeing Machines (AIM: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical. www.seeingmachines.com

Seeing Machines logo

Video - https://www.youtube.com/watch?v=e7tTmzZyjk4

Logo - https://mma.prnewswire.com/media/1247670/Seeing_Machines_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/seeing-machines-unveils-latest-guardian-technology-at-ces-2024-302029214.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.